BD, Hoʻolaha ʻo Accelerate Diagnostics i ka Hui Kūʻai Kūʻai honua: lawe mai i ka ID antimicrobial wikiwiki, nā diagnostics susceptibility i nā kauka hou aku, nā maʻi.

FRANKLIN LAKES, NJ - a me TUCSON, Ariz. BD (Becton, Dickinson and Company) (NYSE: BDX), he hui ʻenehana lapaʻau koʻikoʻi honua, a ʻo Accelerate Diagnostics, Inc. (NASDAQ: AXDX) he mea hoʻomohala i nā diagnostics in-vitro wikiwiki. i ka microbiology, i kēia lā ua hoʻolaha aku i kahi kuʻikahi koʻikoʻi o ka honua holoʻokoʻa kahi e hāʻawi ai ʻo BD i ka hopena hoʻāʻo wikiwiki a Accelerate no ke kūʻē antibiotic a me ka hāʻawi ʻana i nā hopena i nā hola, kūʻē i hoʻokahi a ʻelua mau lā me kekahi mau hana hoʻokolohua kuʻuna.

Ma lalo o ka ʻaelike, e kūʻai aku a kūʻai aku ʻo BD i ka ʻōnaehana Accelerate Pheno® a me Accelerate Arc™ module a me nā pahu hoʻāʻo e pili ana ma o kāna pūnaewele kūʻai honua ma nā ʻāina kahi i loaʻa ai ka ʻae kānāwai a i ʻole ke kākau inoa ʻana o nā huahana.Hoʻopiha kēia mau ʻoluʻolu i kā BD Clinical Microbiology portfolio a holomua i ka pahuhopu like o nā ʻoihana ʻelua e hoʻoponopono i ka hoʻoweliweli honua o ke kū'ē antimicrobial.

"Ke maʻi nui ka mea maʻi, he mea nui kēlā me kēia minuke," wahi a Brooke Story, pelekikena o Integrated Diagnostic Solutions no BD."Hiki i ka hoʻāʻo wikiwiki ke hoʻoholo inā pono e hoʻohana ʻia kahi lāʻau antibiotic no ka mālama ʻana, a inā pēlā, ʻo wai.Ma o kā mākou hui pū ʻana me Accelerate Diagnostics, hiki iā mākou ke kōkua i nā kauka lapaʻau i ʻoi aku ka wikiwiki, maikaʻi a mālama pono i nā mea maʻi, hiki ke alakaʻi i ka hōʻemi ʻana i nā kumukūʻai mālama olakino a kōkua i ka hoʻolōʻihi ʻana i ka hoʻolaha ʻana o ka antimicrobial resistance.

ʻO ka pahu Accelerate PhenoTest® BC ka hoʻāʻo mua i hoʻomaʻemaʻe ʻia e ka US Food and Drug Administration e hiki ke hāʻawi i ka ʻike wikiwiki a me ka hopena antibiotic susceptibility phenotypic i nā hola pololei mai nā moʻomeheu koko maikaʻi.Hōʻike nā haʻawina hou i waho i kēia hopena e hāʻawi i nā hopena i hoʻokahi a ʻelua mau lā ʻoi aku ka wikiwiki ma mua o nā ʻano hana keʻena hana kuʻuna, hiki ke komo i nā laʻana moʻomeheu no 18 a 24 mau hola, a laila e hana i kahi hoʻāʻo susceptibility hiki ke lawe i ʻewalu a 24 mau hola i ka hopena.ʻO kēia ka mea hiki i nā kauka ke koho pono i ka koho antibiotic a me ke ʻano kikoʻī i ka mea maʻi hoʻokahi, i nā lā ma mua.Ua hoʻokumu maikaʻi ʻia i loko o nā puke i loiloi ʻia e ka hoʻomaikaʻi ʻana i ka manawa i ka lāʻau lapaʻau maikaʻi loa e pōmaikaʻi i nā hopena maʻi a me nā hana o ka haukapila.

ʻO ka Accelerate Arc™ module he ʻōnaehana haʻahaʻa-a-hele maʻalahi e hoʻopau i ka pono o kahi subculture no MALDI ID a me ka pono no ka manawa lima lōʻihi ma o ka hoʻomaʻamaʻa ʻana i ke kahe hana MALDI ID pololei.I kēia manawa ʻo US, CE-IVDR a me UKCA i hoʻopaʻa inoa ʻia no nā moʻomeheu koko maikaʻi.

"Me ka waihona nui o ka mea kūʻai aku o BD o nā ʻōnaehana microbiology clinical, hoʻonui nui kēia hui ʻana i kā mākou ʻoihana kūʻai honua a hāʻawi i nā ala he nui e hoʻonui ai i kā mākou mākeke me Pheno a me Arc e hiki aku ai i nā kauka a me nā mea maʻi," wahi a Jack Phillips, pelekikena a Luna Nui o Accelerate ʻIkepili."Ma waho aʻe o nā pono lapaʻau a me nā ʻoihana pāʻoihana, hauʻoli mākou i ka manawa kūpono e hui pū me BD ma ke ʻano he alakaʻi lōʻihi i ka microbiology clinical."

Ke Au Lapaau Lapaau


Ka manawa hoʻouna: Sep-01-2022